SEC Form 4 · accession 0001613377-17-000005
AIM ImmunoTech Inc. · AIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam Pascale
Officer — CFO
Period of report
May 2, 2017
Accepted (ET)
May 2, 2017 · 2:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 2, 2017 | P | 15,873 | $0.63 | A | 27,389 | D |
Table II — derivative securities
No Table II lines on this filing.